Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
19/03/202506:40Alliance NewsAlliance NewsSickness benefits bill "devastating", UK PM says as defends reforms
19/03/202506:40PR Newswire (US)AquaSculpt Cracks Down on Unauthorized Sellers as Supplement Industry Faces Counterfeit Surge
19/03/202506:37PR Newswire (US)AquaSculpt Cracks Down on Unauthorized Sellers as Supplement Industry Faces Counterfeit Surge
19/03/202506:36Alliance NewsAlliance NewsUnredacted JFK assassination files released following order by Trump
19/03/202506:31Alliance NewsAlliance NewsGET READY: Prudential, Judges Scientific and Hutchmed at 0700 GMT
19/03/202506:30Alliance NewsAlliance NewsAlliance News UK - start of day
19/03/202506:30UK RegulatoryTransaction in Own SharesTG:6E2Endeavour Mining Corp
19/03/202506:30UK RegulatoryONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update WebcastTG:63EOnward Medical NV
19/03/202506:30UK RegulatoryNicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma TrialEU:ALCOXNicox SA
19/03/202506:30UK RegulatoryONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update WebcastEU:ONWDOnward Medical NV
19/03/202506:30UK RegulatoryNicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma TrialLSE:0RCQNicox Sa
19/03/202506:30UK RegulatoryNicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucomeLSE:0RCQNicox Sa
19/03/202506:30UK RegulatoryNicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucomeEU:ALCOXNicox SA
19/03/202506:30UK RegulatoryNicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucomeTG:NXOANicox SA
19/03/202506:30UK RegulatoryNicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma TrialTG:NXOANicox SA
19/03/202506:30UK RegulatoryTransaction in Own SharesLSE:EDVEndeavour Mining Plc
19/03/202506:17PR Newswire (US)Empowering Education in Africa: Bybit and AltSchool Africa Unveil Bybit Academy and $100,000 Scholarship Fund
19/03/202506:03PR Newswire (US)Empowering Education in Africa: Bybit and AltSchool Africa Unveil Bybit Academy and $100,000 Scholarship Fund
19/03/202506:01Alliance NewsAlliance NewsCORRECT: Japan keeps interest rates at 0.5%, February trade surplus
19/03/202506:01PR Newswire (US)ProDentim Warns Consumers About Fake Listings as Counterfeit Supplement Market Expands
19/03/202506:00UK RegulatoryIpsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'eurosTG:I7GIpsen SA
19/03/202506:00UK RegulatoryIpsen announces issuance of €500 million inaugural Rated Public BondEU:IPNIpsen SA
19/03/202506:00UK RegulatoryPrimo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market
19/03/202506:00UK RegulatoryIpsen announces issuance of €500 million inaugural Rated Public BondTG:I7GIpsen SA
19/03/202506:00UK RegulatoryIpsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'eurosEU:IPNIpsen SA
19/03/202506:00UK RegulatoryStart of Day Message
19/03/202506:00UK RegulatoryBiotalys Reports Full-Year 2024 Financial Results and Business HighlightsEU:BTLSBiotalys
19/03/202506:00PR Newswire (US)TECO Acquires Malaysia's NCL Energy to Enter Southeast Asia's Data Center MEP Engineering Market
19/03/202506:00UK RegulatoryPR Newswire - Start of Day
19/03/202506:00PR Newswire (US)ROHM's "Power Eco Family": Pioneering Next-generation Power Solutions